Evaluation of a pharmacist-managed diabetes medication therapy adherence clinic
- PMID: 25126149
- PMCID: PMC4127064
- DOI: 10.4321/s1886-36552010000400008
Evaluation of a pharmacist-managed diabetes medication therapy adherence clinic
Abstract
Patient adherence to prescribed medication regimens is important in diabetes care to prevent or delay microvascular and macrovascular complications such as retinopathy, nephropathy and myocardial infarction. In Penang Hospital, Malaysia, pharmacists collaborate with physicians in diabetes care through a pharmacist-managed Diabetes Medication Therapy Adherence Clinic (DMTAC) in the Endocrine Clinic, in operation since 2006.
Objective: To evaluate the effectiveness of the pharmacist-managed DMTAC program in improving glycaemic control, lipid parameters and patients' medication adherence.
Method: A retrospective study among patients enrolled in the DMTAC program was conducted between September 2007 and December 2008. Data was included from patients with a glycosylated haemoglobin (HbA1c) >8% and who had completed eight visits with the pharmacists. Medical records and DMTAC forms that provided patients' demographics, medication regimens, adherence and laboratory parameters as well as pharmacists' interventions were reviewed. HbA1c, fasting blood glucose (FBG), low-density lipoprotein cholesterol (LDL), triglycerides (TG) and high-density lipoprotein cholesterol (HDL) were evaluated. Documented data of patients' adherence to medication regimen [Modified Morisky Medication Adherence Score (MMMAS); high adherence if score >8, medium adherence if score 6 to <8 and low adherence if score <6] was also evaluated.
Results: A total of 43 patients (53.5% females; 46.5% Malays, 44.2% Chinese and 9.3% Indians) were included in the analysis. A mean reduction in HbA1c of 1.73% (p<0.001), mean reduction in FBG of 2.65mmol/l (p=0.01) and mean reduction in LDL cholesterol of 0.38mmol/l (p=0.007) were achieved. The difference in TG and HDL cholesterol were not significant. Patients' adherence to medication regimens improved significantly with an increase in the mean MMMAS score from 7.00 to 10.84 (p<0.001) after completion of the DMTAC program.
Conclusion: The pharmacist-managed DMTAC program resulted in significant improvements in HbA1c, glucose and LDL cholesterol levels as well as medication adherence in patients with diabetes.
Keywords: Diabetes; Malaysia; Medication Adherence; Pharmacists.
Conflict of interest statement
The authors have no financial or other conflict of interests that could inappropriately influence or bias the authors’ decision in relation to the manuscript submitted. No sponsorship or funding.
Figures
Similar articles
-
A retrospective multicentre study on the outcomes of the pharmacist-managed Diabetes Medication Therapy Adherence Clinic programme in primary health clinics across Johor, Malaysia.Malays Fam Physician. 2025 Jun 24;20:43. doi: 10.51866/oa.767. eCollection 2025. Malays Fam Physician. 2025. PMID: 40662123 Free PMC article.
-
The impact of pharmacist interventions, follow-up frequency and default on glycemic control in Diabetes Medication Therapy Adherence Clinic program: a multicenter study in Malaysia.J Pharm Policy Pract. 2023 Jul 5;16(1):83. doi: 10.1186/s40545-023-00583-8. J Pharm Policy Pract. 2023. PMID: 37408067 Free PMC article.
-
Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.Pak J Pharm Sci. 2016 Mar;29(2):595-601. Pak J Pharm Sci. 2016. PMID: 27087103 Clinical Trial.
-
Medication Adherence of Persons with Type 2 Diabetes in Malaysia: A Scoping Review and Meta-Analysis.J ASEAN Fed Endocr Soc. 2022;37(1):75-82. doi: 10.15605/jafes.037.01.14. Epub 2022 Apr 30. J ASEAN Fed Endocr Soc. 2022. PMID: 35800597 Free PMC article.
-
Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis.Front Pharmacol. 2017 Dec 14;8:891. doi: 10.3389/fphar.2017.00891. eCollection 2017. Front Pharmacol. 2017. PMID: 29311916 Free PMC article. Review.
Cited by
-
Effect of number and type of antidiabetes medications on adherence and glycemia of ambulatory type 2 diabetes patients in southwestern Nigeria.Pharm Pract (Granada). 2013 Jul;11(3):156-65. doi: 10.4321/s1886-36552013000300006. Epub 2013 Sep 20. Pharm Pract (Granada). 2013. PMID: 24223081 Free PMC article.
-
Barriers and facilitators to patient-centred care in pharmacy consultations: A qualitative study with Malaysian hospital pharmacists and patients.PLoS One. 2021 Oct 7;16(10):e0258249. doi: 10.1371/journal.pone.0258249. eCollection 2021. PLoS One. 2021. PMID: 34618863 Free PMC article.
-
Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey.Pharm Pract (Granada). 2012 Oct;10(4):207-21. doi: 10.4321/s1886-36552012000400005. Epub 2012 Dec 31. Pharm Pract (Granada). 2012. PMID: 24155839 Free PMC article.
-
Health care consumers' perspectives on pharmacist integration into private general practitioner clinics in Malaysia: a qualitative study.Patient Prefer Adherence. 2015 Mar 19;9:467-77. doi: 10.2147/PPA.S73953. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 25834411 Free PMC article.
-
A digital health-supported and community pharmacy-based lifestyle intervention program for adults with pre-diabetes: a study protocol for a cluster randomised controlled trial.BMJ Open. 2024 Oct 23;14(10):e083921. doi: 10.1136/bmjopen-2024-083921. BMJ Open. 2024. PMID: 39448216 Free PMC article.
References
-
- Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2003. Diabetes Care. 2004;27:1047–1053. - PubMed
-
- Mafauzy M. Diabetes Mellitus in Malaysia. Med J Malaysia. 2006;61(4):397–398. - PubMed
-
- The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. - PubMed
-
- U.K. Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352(9131):837–853. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous